R103L (p.Arg103Leu) variant of SV2A (Synaptic vesicle glycoprotein 2A)

R103L (p.Arg103Leu) in SV2A (Synaptic vesicle glycoprotein 2A) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes population frequency data and structural context.

R103L (p.Arg103Leu) variant details